Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Nasopharyngeal Carcinoma 6Colorectal Neoplasms 4Lung Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Neoplasms 2Nasopharyngeal Neoplasms 2Head and Neck Neoplasms 2Squamous Non-small Cell Lung Cancer 1Sarcoma 1Recurrence 1Neuroblastoma 1Meningeal Carcinomatosis 1Melanoma 1Lymphoma, T-Cell 1Locally Advanced Squamous Non-small Cell Lung Cancer 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Breast Cancer Organoids 1Advanced Pancreatic Cancer 1Adenoviridae Infections 1Adenocarcinoma of Lung 1

Interventions

Gefitinib 9Pemetrexed 7Carboplatin 5Gemcitabine 4Cisplatin 4apatinib 3Docetaxel 3aflutinib 2Neoadjuvant Therapy 2Erlotinib Hydrochloride 2Bevacizumab 2tislelizumab 1pembrolizumab 1motesanib diphosphate 1lometrexol 1icotinib 1endostar protein 1camrelizumab 1Watchful Waiting 1Thymalfasin 1Radiomics 1Platinum Compounds 1Paclitaxel 1Lymph Node Excision 1Indium 1Immune Checkpoint Inhibitors 1High-Throughput Nucleotide Sequencing 1Folic Acid 1Exome 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Adenocarcinoma of Lung × Endostatins × Clear all
NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Anhui Provincial Hospital

Phase 4 Unknown
100 enrolled
Thoracic

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡